Literature DB >> 10755079

Smoking habits and plasma lipid peroxide and vitamin E levels in never-treated first-episode patients with schizophrenia.

.   

Abstract

BACKGROUND: Lipid peroxidation may be increased in schizophrenia, due to the illness, lifestyle or medication. AIMS: To determine plasma lipid peroxide levels and serum vitamin E and A levels in first-episode never-treated people with schizophrenia and in controls.
METHOD: Thirty in-patients with a first episode of schizophrenia or schizophreniform psychosis were recruited, as were controls matched for gender, age, smoking and dietary status. Blood samples were taken, smoking status was recorded and body mass index measured.
RESULTS: There were no significant differences between patients and controls in plasma peroxide levels. Seventy-three per cent of the patients smoked. Patients who smoked had a higher mean lipid peroxide level than non-smokers. Seventy-seven per cent of patients and 70% of controls had a ratio of vitamin E to cholesterol of less than 5. Body mass index was lower in patients than in controls.
CONCLUSIONS: As a result of the high prevalence of smoking this group shows increased lipid peroxidation. Low serum ratios of vitamin E to cholesterol in both patients and controls suggest an unsatisfactory diet.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10755079     DOI: 10.1192/bjp.176.3.290

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  6 in total

Review 1.  Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.

Authors:  Jeffrey K Yao; Matcheri S Keshavan
Journal:  Antioxid Redox Signal       Date:  2011-04-21       Impact factor: 8.401

2.  Meta-analysis of oxidative stress in schizophrenia.

Authors:  Joshua Flatow; Peter Buckley; Brian J Miller
Journal:  Biol Psychiatry       Date:  2013-05-15       Impact factor: 13.382

Review 3.  Does tobacco use cause psychosis? Systematic review and meta-analysis.

Authors:  Pedro Gurillo; Sameer Jauhar; Robin M Murray; James H MacCabe
Journal:  Lancet Psychiatry       Date:  2015-07-09       Impact factor: 27.083

4.  Evaluation of Paraoxonase, Arylesterase and Malondialdehyde Levels in Schizophrenia Patients Taking Typical, Atypical and Combined Antipsychotic Treatment.

Authors:  Mehmet Güneş; Mehmet Akif Camkurt; Mahmut Bulut; Süleyman Demir; Aslıhan Okan İbiloğlu; Mehmet Cemal Kaya; Abdullah Atlı; İbrahim Kaplan; Aytekin Sir
Journal:  Clin Psychopharmacol Neurosci       Date:  2016-11-30       Impact factor: 2.582

5.  Nutritional Deficiencies and Clinical Correlates in First-Episode Psychosis: A Systematic Review and Meta-analysis.

Authors:  Joseph Firth; Rebekah Carney; Brendon Stubbs; Scott B Teasdale; Davy Vancampfort; Philip B Ward; Michael Berk; Jerome Sarris
Journal:  Schizophr Bull       Date:  2018-10-17       Impact factor: 9.306

6.  Is dietary pattern of schizophrenia patients different from healthy subjects?

Authors:  Reza Amani
Journal:  BMC Psychiatry       Date:  2007-05-02       Impact factor: 3.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.